
<collection>
    <source>hpo-corpus-1</source>
    <date>20250615</date>
    <key>INITIAL_CAS</key>
    <document>
        <id>INITIAL_CAS</id>
        <passage>
            <offset>0</offset>
            <sentence>
                <offset>0</offset>
                <text>Individual 13 is a 24-year-old male with intellectual disability (non-verbal), autism, global developmental delay, hypotonia, ataxic gait, and generalized epilepsy (multi-drug resistant).</text>
            </sentence>
            <sentence>
                <offset>188</offset>
                <text>Epilepsy began at age 6.</text>
            </sentence>
            <sentence>
                <offset>213</offset>
                <text>Height is 162.6 cm (-1.98 SD).</text>
            </sentence>
            <sentence>
                <offset>244</offset>
                <text>He struggles to maintain his weight, which is 49 kg (-2.69 SD) (body mass index 18.5).</text>
            </sentence>
            <sentence>
                <offset>331</offset>
                <text>Physical exam was notable for ptosis, low-set ears, small feet with high arches and hammertoes, asymmetric thumb nailbeds with left wider than right, hypotonia, and poor coordination.</text>
            </sentence>
            <sentence>
                <offset>515</offset>
                <text>Brain MRI was reportedly normal.</text>
            </sentence>
            <sentence>
                <offset>548</offset>
                <text>Trio exome sequencing (GeneDx, Gaithersburg, MD) identified a de novo variant in POLR1A c.3988_3990delGAG; p.</text>
            </sentence>
            <sentence>
                <offset>658</offset>
                <text>(Glu1330del) as well as a de novo variant in ATP1A1 c.2769C&gt;A; p.</text>
            </sentence>
            <sentence>
                <offset>723</offset>
                <text>(Phe923Leu) (NM_000701.8, GRCH38).</text>
            </sentence>
            <sentence>
                <offset>758</offset>
                <text>Both are classified as likely pathogenic.</text>
            </sentence>
            <sentence>
                <offset>800</offset>
                <text>Heterozygous variants in ATP1A1 have recently been associated with a small number of cases of variable neurologic phenotypes ranging from Charcot-Marie-Tooth (peripheral neuropathy) to seizures and intellectual disability4-6 .</text>
            </sentence>
            <sentence>
                <offset>1027</offset>
                <text>Thus, it is possible that both de novo variants contribute to this individualâ€™s phenotype (ATP1A1 and POLR1A to neurodevelopmental abnormalities, ATP1A1 to hammer toes and high arches, POLR1A to craniofacial features and wide left thumb nailbed).</text>
            </sentence>
            <sentence>
                <offset>1274</offset>
                <text>Of note, an individual with a missense variant in ATP1A1 at the same codon c.2768T&gt;A, encoding p.</text>
            </sentence>
            <sentence>
                <offset>1371</offset>
                <text>(Phe923Tyr) and reported by Dohrn et al (2022), did not have epilepsy.</text>
            </sentence>
        </passage>
    </document>
</collection>
